Evaluating the efficacy of new inotropic agents (Q71328286)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6715715 AND SRC:MED&resulttype=core&format=json

17 October 2019

title

Evaluating the efficacy of new inotropic agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6715715 AND SRC:MED&resulttype=core&format=json

17 October 2019

author name string

E Braunwald

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6715715 AND SRC:MED&resulttype=core&format=json

17 October 2019

W S Colucci

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6715715 AND SRC:MED&resulttype=core&format=json

17 October 2019

language of work or name

English

0 references

publication date

1 June 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6715715 AND SRC:MED&resulttype=core&format=json

Journal of the American College of Cardiology

17 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6715715 AND SRC:MED&resulttype=core&format=json

17 October 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6715715 AND SRC:MED&resulttype=core&format=json

17 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6715715 AND SRC:MED&resulttype=core&format=json

17 October 2019

page(s)

1570-1574

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6715715 AND SRC:MED&resulttype=core&format=json

Hemodynamic assessment of amrinone. A new inotropic agent

17 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

Decreased Lymphocyte Beta-Adrenergic-Receptor Density in Patients with Heart Failure and Tolerance to the Beta-Adrenergic Agonist Pirbuterol

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

Long-term therapy with a new cardiotonic agent, WIN 47203: drug-dependent improvement in cardiac performance and progression of the underlying disease

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

Effects of AR-L 115 BS (Sulmazol), a new cardiotonic agent, in coronary artery disease: improved ventricular wall motion, increased pump function and abolition of pacing-induced ischemia.

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

Stimulation of Ca binding and ATPase activity of dog cardiac myofibrils by AR-L 115BS, a novel cardiotonic agent

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

Cardiovascular effects of a newly synthesized cardiotonic agent (TA-064) on normal and diseased hearts

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

Hemodynamic effects of prenalterol in patients with ischemic heart disease and congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

Effects of a cardioselective beta1 partial agonist (corwin) on left ventricular function and myocardial metabolism in patients with previous myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

Left ventricular end-systolic stress-shortening and stress-length relations in human. Normal values and sensitivity to inotropic state

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

CLINICAL OBSERVATIONS ON PAIRED ELECTRICAL STIMULATION OF THE HEART. EFFECTS ON VENTRICULAR PERFORMANCE AND HEART RATE

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

Immediate effects of hydralazine-isosorbide dinitrate combination on exercise capacity and exercise hemodynamics in patients with left ventricular failure

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

Drug-induced conditioning in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

Mechanisms and implications of vasodilator tolerance in the treatment of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

Failure of dobutamine to increase exercise capacity despite hemodynamic improvement in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

Long-term digitalis therapy improves left ventricular function in heart failure

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

Effects of discontinuing maintenance digoxin therapy in patients with ischemic heart disease and congestive heart failure in sinus rhythm

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

Adverse effects of long-term amrinone administration in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

A new inotropic drug: its promise and a caution

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

Control of myocardial oxygen consumption: physiologic and clinical considerations

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

Effects of amrinone on experimental acute myocardial ischaemic injury

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

The Natural History of Congestive Heart Failure: The Framingham Study

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

The natural history of idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

Determinants of clinical response and survival in patients with congestive heart failure treated with captopril

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements.

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

The effect of coronary bypass surgery on survival

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(84)80299-5

7 January 2021

10.1016/S0735-1097(84)80299-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6715715 AND SRC:MED&resulttype=core&format=json

17 October 2019

1 reference